These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 6691883

  • 1. Iron absorption from 'Feospan' capsules and ferrous sulphate tablets B.P.
    Fitzsimons EJ, Thomson W, Jacobs A.
    Br J Clin Pharmacol; 1984 Jan; 17(1):111-3. PubMed ID: 6691883
    [No Abstract] [Full Text] [Related]

  • 2. Fractional iron absorption from enteric-coated ferrous sulphate tablet.
    Thankachan P, Bose B, Subramanian R, Koneri R, Kurpad AV.
    Indian J Med Res; 2020 Apr; 151(4):371-374. PubMed ID: 32461401
    [Abstract] [Full Text] [Related]

  • 3. Absorption from different types of iron tablets - correlation between serum iron increase in total absorption of iron.
    Ekenved G.
    Scand J Haematol Suppl; 1976 Apr; 28():51-63. PubMed ID: 1064902
    [Abstract] [Full Text] [Related]

  • 4. Absorption and side-effects after peroral administration of sustained release iron tablets. Ferro-Retard compared with Ferronicum and Duroferon Duretter.
    Levy F, Anderson P, Ekren T.
    Acta Med Scand; 1978 Apr; 204(4):303-10. PubMed ID: 358765
    [Abstract] [Full Text] [Related]

  • 5. Influence of a liquid antacid on the absorption of different iron salts.
    Ekenved G, Halvorsen L, Sölvell L.
    Scand J Haematol Suppl; 1976 Apr; 28():65-77. PubMed ID: 1064903
    [Abstract] [Full Text] [Related]

  • 6. Biopharmaceutical evaluation of ferrous salts in form of oral long-acting tablets.
    Krzyśko K, Bokowski W, Wichliński LM.
    Pol J Pharmacol Pharm; 1984 Apr; 36(1):73-7. PubMed ID: 6462964
    [Abstract] [Full Text] [Related]

  • 7. A TRIAL OF SLOW-RELEASE TABLETS OF FERROUS SULPHATE.
    CROSLAND-TAYLOR P, KEELING DH, CROMIE BW.
    Curr Ther Res Clin Exp; 1965 Apr; 7():244-8. PubMed ID: 14276016
    [No Abstract] [Full Text] [Related]

  • 8. Effect of dose and formulation on iron tolerance in pregnancy.
    Shatrugna V, Raman L, Kailash U, Balakrishna N, Rao KV.
    Natl Med J India; 1999 Apr; 12(1):18-20. PubMed ID: 10326325
    [Abstract] [Full Text] [Related]

  • 9. A profile scanning method of studying the release properties of different types of tablets in man.
    Alpsten M, Ekenved G, Sölvell L.
    Acta Pharm Suec; 1976 Apr; 13(2):107-22. PubMed ID: 937006
    [No Abstract] [Full Text] [Related]

  • 10. A comparative trial of a controlled-release iron tablet preparation ('Ferrocontin' Continus) and ferrous fumarate tablets.
    Aronstam A, Aston DL.
    Pharmatherapeutica; 1982 Apr; 3(4):263-7. PubMed ID: 7146040
    [Abstract] [Full Text] [Related]

  • 11. Iron Pharmacokinetics in Women with Iron Deficiency Anaemia Following A Single Oral Dose of a Novel Formulation of Tardyferon (Prolonged Release Ferrous Sulphate).
    Leary A, Barthe L, Clavel T, Sanchez C, Issiakhem Z, Paillard B, Edmond JM.
    Drug Res (Stuttg); 2017 Nov; 67(11):647-652. PubMed ID: 28724166
    [Abstract] [Full Text] [Related]

  • 12. Adverse effects of iron supplementation: a comparative trial of a wax-matrix iron preparation and conventional ferrous sulfate tablets.
    Brock C, Curry H, Hanna C, Knipfer M, Taylor L.
    Clin Ther; 1985 Nov; 7(5):568-73. PubMed ID: 4053146
    [Abstract] [Full Text] [Related]

  • 13. Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers.
    Walker SE, Paton TW, Cowan DH, Manuel MA, Dranitsaris G.
    CMAJ; 1989 Sep 15; 141(6):543-7. PubMed ID: 2776093
    [Abstract] [Full Text] [Related]

  • 14. Iron absorption by human subjects from different iron fortification compounds added to Thai fish sauce.
    Walczyk T, Tuntipopipat S, Zeder C, Sirichakwal P, Wasantwisut E, Hurrell RF.
    Eur J Clin Nutr; 2005 May 15; 59(5):668-74. PubMed ID: 15756294
    [Abstract] [Full Text] [Related]

  • 15. Comparison study of oral iron preparations using a human intestinal model.
    Zariwala MG, Somavarapu S, Farnaud S, Renshaw D.
    Sci Pharm; 2013 May 15; 81(4):1123-39. PubMed ID: 24482777
    [Abstract] [Full Text] [Related]

  • 16. Comparison of flame atomic absorption spectrometry (FAAS) and Cerimetric methods for the determination of ferrous sulfate content of some pharmaceutical products.
    Zahra R, Nadere R, Azam G.
    Pak J Pharm Sci; 2008 Oct 15; 21(4):396-9. PubMed ID: 18930861
    [Abstract] [Full Text] [Related]

  • 17. Absorption of slow-release iron and effects of ascorbic acid in normal subjects and after partial gastrectomy.
    Baird IM, Walters RL, Sutton DR.
    Br Med J; 1974 Nov 30; 4(5943):505-8. PubMed ID: 4215536
    [Abstract] [Full Text] [Related]

  • 18. [Oral iron therapy. Bioavailability and therapeutic effectiveness of ferrous iron in effervescent tablets in posthemorrhagic iron deficiency anemia].
    Kaltwasser JP, Schwarz-van de Sand W.
    Dtsch Med Wochenschr; 1989 Aug 04; 114(31-32):1188-95. PubMed ID: 2666080
    [Abstract] [Full Text] [Related]

  • 19. [Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron].
    Casparis D, Del Carlo P, Branconi F, Grossi A, Merante D, Gafforio L.
    Minerva Ginecol; 1996 Nov 04; 48(11):511-8. PubMed ID: 9005381
    [Abstract] [Full Text] [Related]

  • 20. Semiautomated method for determining ferrous sulfate in pharmaceuticals: collaborative study.
    McCullen PA.
    J Assoc Off Anal Chem; 1978 Jul 04; 61(4):968-70. PubMed ID: 681270
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.